The research at the Bose Lab lies at the interface of biomaterial science, cellular engineering, and drug delivery with the aim of creating next-generation cell-based therapies for a wide range of human diseases. The lab combines multiscale device fabrication, material chemistry, and cell engineering principles to develop platform technologies capable of delivering precise doses of drugs (biologics) at the right location in the body at the right time. These platforms have applications in treating chronic diseases such as diabetes and liver failure, immune engineering applications in cancer and autoimmunity, and regenerative medicine.